Literature DB >> 10950115

Proliferative heterogeneity in the human prostate: evidence for epithelial stem cells.

D L Hudson1, M O'Hare, F M Watt, J R Masters.   

Abstract

Clonal analysis of human prostate epithelial cells was undertaken in order to identify stem cells. Two types of colony were distinguished, termed type I and type II. Type I colonies were relatively small and irregular and contained a loose mixture of differentiated and undifferentiated cells. In contrast, type II colonies were large, round, and homogeneous, consisting almost exclusively of small undifferentiated and dividing cells. The colony-forming efficiency was 5.8% +/- 1.8 for freshly isolated epithelial cells. There were approximately 10 times as many type I as type II colonies and about 1 in 200 of the plated cells was capable of forming a type II colony. In three-dimensional culture on Matrigel, the type II colonies produced structures reminiscent of prostate epithelium, with luminal cells expressing markers of prostate epithelial differentiation, including the androgen receptor. On the basis of their proliferative characteristics and pluripotency, the type II colonies may be the progeny of stem cells and the type I colonies of a more differentiated transit-amplifying population.

Entities:  

Mesh:

Year:  2000        PMID: 10950115     DOI: 10.1038/labinvest.3780132

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  42 in total

1.  Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties.

Authors:  Thorarinn Gudjonsson; René Villadsen; Helga Lind Nielsen; Lone Rønnov-Jessen; Mina J Bissell; Ole William Petersen
Journal:  Genes Dev       Date:  2002-03-15       Impact factor: 11.361

2.  Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and nonside population cell fractions from human invasive prostate cancer cells.

Authors:  Murielle Mimeault; Sonny L Johansson; Jean-Pierre Henichart; Patrick Depreux; Surinder K Batra
Journal:  Mol Cancer Ther       Date:  2010-02-23       Impact factor: 6.261

Review 3.  Stem cells in prostate cancer initiation and progression.

Authors:  Devon A Lawson; Owen N Witte
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 4.  Prostate epithelial stem cells.

Authors:  S Rizzo; G Attard; D L Hudson
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

5.  Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique.

Authors:  S G Jhavar; C Fisher; A Jackson; S A Reinsberg; N Dennis; A Falconer; D Dearnaley; S E Edwards; S M Edwards; M O Leach; C Cummings; T Christmas; A Thompson; C Woodhouse; S Sandhu; C S Cooper; R A Eeles
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

6.  Isolation and functional characterization of murine prostate stem cells.

Authors:  Devon A Lawson; Li Xin; Rita U Lukacs; Donghui Cheng; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 11.205

7.  Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells.

Authors:  Ivan V Litvinov; Donald J Vander Griend; Yi Xu; Lizamma Antony; Susan L Dalrymple; John T Isaacs
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

8.  Anchorage-independent culture maintains prostate stem cells.

Authors:  Xudong Shi; Jerry Gipp; Wade Bushman
Journal:  Dev Biol       Date:  2007-09-29       Impact factor: 3.582

9.  The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.

Authors:  Donald J Vander Griend; Wouter L Karthaus; Susan Dalrymple; Alan Meeker; Angelo M DeMarzo; John T Isaacs
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

10.  Neuroendocrine differentiation in prostate cancer.

Authors:  Yin Sun; Junyang Niu; Jiaoti Huang
Journal:  Am J Transl Res       Date:  2009-02-05       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.